SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for GSK (GSK) — Aug 20, 2013

GSK plc
Date: Aug. 20, 2013 · CIK: 0001131399 · Accession: 0000000000-13-045821

AI Filing Summary & Sentiment

File numbers found in text: 001-15170

Date
Aug. 20, 2013
Author
/s/ Joel Parker
Form
UPLOAD
Company
GSK plc

Letter

August 20 , 2013 Via E-mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, Middlesex TW8 9GS England

Re: GlaxoSmithKline plc Form 20-F for the Year Ended December 31 , 2012 Filed March 8, 201 3 File No. 001-15170

Dear M r. Dingemans :

We have comple ted our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Joel Parker

Show Raw Text
August 20 , 2013

Via E-mail
Mr. Simon Dingemans
Chief Financial Officer
GlaxoSmithKline plc
980 Great West Road
Brentford, Middlesex
TW8 9GS
England

 Re: GlaxoSmithKline plc
  Form 20-F for the Year Ended December 31 , 2012
  Filed March  8, 201 3
File No.  001-15170

Dear M r. Dingemans :

We have comple ted our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

/s/ Joel Parker

Joel Parker
Accounting Branch Chief